bimatoprost 0.03 % Eyelash Topical Solution

RxCUI
1041495
RxNorm name
bimatoprost 0.03 % Eyelash Topical Solution
Display name
bimatoprost 0.03 % Eyelash Topical Solution
Full name
bimatoprost 0.03 % Eyelash Topical Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:53

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
bimatoprostBIMATOPROSTAlembic Pharmaceuticals Inc.dfb6eabf-d8e0-4fd3-8ef6-c646da7a987d2025-12-10Warnings, Adverse reactionsExact identifier
rxcui: 1041495
LATISSEBIMATOPROSTAllergan, Inc.34f83d9d-2c64-463e-8a90-9a460fedfead2024-07-01Warnings, Adverse reactionsExact identifier
rxcui: 1041495
BimatoprostBIMATOPROSTSandoz Inc27bef7e1-750a-4ac1-ab5f-e4c0121ffcbc2023-08-31Warnings, Adverse reactionsExact identifier
rxcui: 1041495

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
34f83d9d-2c64-463e-8a90-9a460fedfeadbimatoprost 0.03 % Eyelash Topical SolutionPSN25These highlights do not include all the information needed to use LATISSE safely and effectively. See full prescribing information for LATISSE. LATISSE ® (bimatoprost ophthalmic solution) 0.03% , for topical ophthalmic use Initial U.S. Approval: 200120240701
34f83d9d-2c64-463e-8a90-9a460fedfeadbimatoprost 0.3 MG/ML Topical SolutionSCD25These highlights do not include all the information needed to use LATISSE safely and effectively. See full prescribing information for LATISSE. LATISSE ® (bimatoprost ophthalmic solution) 0.03% , for topical ophthalmic use Initial U.S. Approval: 200120240701
34f83d9d-2c64-463e-8a90-9a460fedfeadbimatoprost 0.03 % Eyelash Topical SolutionSY25These highlights do not include all the information needed to use LATISSE safely and effectively. See full prescribing information for LATISSE. LATISSE ® (bimatoprost ophthalmic solution) 0.03% , for topical ophthalmic use Initial U.S. Approval: 200120240701
27bef7e1-750a-4ac1-ab5f-e4c0121ffcbcbimatoprost 0.03 % Eyelash Topical SolutionPSN22These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, 0.03%, for topical ophthalmic use Initial U.S. Approval: 200120230831
27bef7e1-750a-4ac1-ab5f-e4c0121ffcbcbimatoprost 0.3 MG/ML Topical SolutionSCD22These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, 0.03%, for topical ophthalmic use Initial U.S. Approval: 200120230831
27bef7e1-750a-4ac1-ab5f-e4c0121ffcbcbimatoprost 0.03 % Eyelash Topical SolutionSY22These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, 0.03%, for topical ophthalmic use Initial U.S. Approval: 200120230831
dfb6eabf-d8e0-4fd3-8ef6-c646da7a987dbimatoprost 0.3 MG/ML Topical SolutionSCD15These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution for topical ophthalmic use. Initial U.S. Approval: 200120251210
dfb6eabf-d8e0-4fd3-8ef6-c646da7a987dbimatoprost 0.03 % Eyelash Topical SolutionPSN15These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution for topical ophthalmic use. Initial U.S. Approval: 200120251210
dfb6eabf-d8e0-4fd3-8ef6-c646da7a987dbimatoprost 0.03 % Eyelash Topical SolutionSY15These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution for topical ophthalmic use. Initial U.S. Approval: 200120251210